– PCI Pharma Services (“PCI”), a global CDMO focused on innovative biotherapies, announced a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, with significant reinvestment from Mubadala Investment Company.
– Partners Group will continue to support the company with a minority investment.
– The company offers integrated end-to-end drug development, manufacturing, and packaging services.
– The investment aims to accelerate PCI’s growth, improve customer experience, and expand services and geographic reach.
– PCI will focus on both organic and inorganic growth initiatives.
– Salim Haffar, Chief Executive Officer, PCI Pharma Services: “PCI has embarked on a purposeful journey to transform itself into a global CDMO by executing its successful growth strategy, providing industry-leading customer experience, and offering innovative and integrated supply chain solutions.”
– Matt Jennings, Chairman, PCI Pharma Services and Operating Partner, Kohlberg: “PCI’s world-class management team, combined with the support of experienced industry investors, has proven to be a very successful formula.”
– Devin O’Reilly, Partner, Bain Capital: “Anchored by an innovative, advanced platform that is consistently growing and setting new standards for the industry.”
– Andrew Kaplan and Christina Dix, Partners, Bain Capital: “We are excited to leverage our industry expertise and the collaboration of our global healthcare team to support Salim and PCI’s team of experienced industry leaders in the mission to drive innovation.”
– Chris Anderson, Senior Partner, Kohlberg: “We are honored to have supported PCI’s transformation over the last five years into a leading global CDMO.”
– Mina Hamoodi, Head of Healthcare, Mubadala Investment Company: “Our reinvestment in PCI reflects our deep conviction in the company’s mission, leadership, and long-term potential.”
– Sujit John, Managing Director, Private Equity Health & Life Vertical, Partners Group: “PCI’s market position, reputation, and world-class capabilities strategically position the Company to be the partner of choice for customers.”
– Jefferies LLC acted as lead financial advisor to PCI.
– Moelis & Company acted as co-advisor to PCI.
– Morgan Stanley and Bank of America acted as financial advisors to Bain Capital.
– Citi acted as financial advisor to Mubadala.
– Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal counsel to PCI and Kohlberg.
– Kirkland & Ellis LLP acted as counsel to Bain Capital.
– Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates acted as counsel to Mubadala.
– Ropes & Gray LLP acted as counsel to Partners Group.
